A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Interesting Engineering on MSN5d
New hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 yearsThe U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly ... Citrobacter freundii complex, Enterococcus faecalis, and a type of ...
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older: Philadelphia Friday, March 28, 202 ...
Staphylococcus saprophyticus and Enterococcus faecalis. Blujepa is the first in a new class of oral antibiotics for uncomplicated urinary tract infections approved in nearly 30 years, GSK's Chief ...
TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women ...
The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades ... coli, Klebsiella pneumoniae, Citrobacter freundii complex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback